Relentless Health Value Podcast: Talking Medicare Drug Pricing Negotiations with Dr. Peter Neumann

In the latest episode of the Relentless Health Value podcast, host Stacey Richter sits down with Peter Neumann, ScD, of the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts University to discuss upcoming Medicare drug pricing negotiations. The two discuss how pricing negotiations will account for value and what effects they will have on drug prices for patients.

According to Dr. Neumann, “Bottom line, we want to incent meaningful innovation, drugs that actually work. If we pay a ton of money for drugs that don’t work particularly well, then what’s the incentive to find good drugs? As per my earlier point, if this legislation does as was intended, then good drugs should get rewarded and less comparatively effective drugs should be less rewarded. Let’s cross our fingers, shall we?”

To read more, click here.

(Source: Relentless Health Value, April 20^th, 2023)